Stock Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson to Webcast Annual Meeting of Shareholders

[PR Newswire] – NEW BRUNSWICK, N.J., March 28, 2016 /PRNewswire/ — Johnson & Johnson (JNJ) will webcast its Annual Meeting of Shareholders at 10:00 a.m. (EDT) on Thursday, April 28, 2016, from the State Theatre in New Brunswick, N.J. Investors and other interested parties may access a live video webcast of the meeting by visiting the company’s website at www.jnj.com and clicking on the webcast icon. Caring for the world one person at a time inspires and unites the people of Johnson & Johnson. Read more on this. Johnson & Johnson (JNJ) , currently valued at $298.54B, opened at $108.41. Looking at today’s trading action, the company’s one day range from $108.06 to $108.90 with a trailing 52-week range being $81.79 to $108.90. Priced at 16.64x this year’s forecasted earnings, JNJ shares are relatively expensive compared to the industry’s -5.78x forward p/e ratio. And for those looking to make a return holding the stock, the company pays shareholders $3.00 per share annually in dividends, yielding 2.77%. According to a consensus of 18 analysts, the earnings estimate of $1.66 per share would be $0.10 better than the year-ago quarter and a $0.03 sequential increase. Furthermore, our analysis shows the full-year EPS estimate to be $6.51, which would be a $0.31 better when compared to the last year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $17.47 Billion. If reported, that would be a 0.58% increase over the year-ago quarter. More recently, Goldman upgraded JNJ from Sell to Neutral (Mar 14, 2016). Previously, Barclays downgraded JNJ from Overweight to Equal Weight. When considering if the stock is under or overvalued, the average price target is $109.28, which is 0.80% above where the stock opened this morning. See more in (NYSE:JNJ) Similar Articles: Stock Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson to Participate in Barclays Global Healthcare Conference Market Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson Joins First Industry-wide Call for New Collective Action to Address Antimicrobial Resistance Stock Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson to Participate in the 24th Annual Credit Suisse Health Care Conference